Drug name - Thalomid

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7230012 CELGENE Pharmaceutical compositions and dosage forms of thalidomide
Dec, 2023

(11 months from now)

Drugs and Companies using THALIDOMIDE ingredient

Market Authorisation Date: 16 July, 1998

Treatment: NA


More Information on Dosage
Strength Dosage Availability
50MG CAPSULE;ORAL Prescription
100MG CAPSULE;ORAL Prescription
150MG CAPSULE;ORAL Prescription
200MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in